Avior Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,516
Closed -$742K 862
2026
Q1
$742K Sell
12,516
-897
-7% -$58.2K 0.02% 430
2025
Q4
$827K Sell
13,413
-2,479
-16% -$152K 0.03% 340
2025
Q3
$992K Buy
15,892
+4,087
+35% +$285K 0.03% 300
2025
Q2
$943K Sell
11,805
-19
-0.2% -$1.59K 0.03% 296
2025
Q1
$1.02M Buy
11,824
+3,270
+38% +$268K 0.04% 263
2024
Q4
$668K Buy
8,554
+8,042
+1,571% +$624K 0.02% 372
2024
Q3
$36.9K Hold
512
﹤0.01% 1225
2024
Q2
$35.3K Sell
512
-25
-5% -$1.69K ﹤0.01% 1215
2024
Q1
$39K Buy
+537
New +$35.9K ﹤0.01% 1329

Other funds holding PBH

Avior Wealth Management's PBH Position: Q2 2026 in Review

Avior Wealth Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 12,516 shares — an estimated $742K sold.

Avior Wealth Management first reported a position in PBH in Q1 2024 and held it in 9 quarters. The position peaked at $1.02M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Avior Wealth Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Avior Wealth Management sold 12,516 Prestige Consumer Healthcare shares in Q2 2026, an estimated $742K.
  • Avior Wealth Management first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 9 quarters.
  • Avior Wealth Management's Prestige Consumer Healthcare position peaked at $1.02M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.